In late March, as the coronavirus sent India into a nationwide lockdown, Dr Arvind Lal, 70, sprang into action. His Dr Lal PathLabs, one of India's largest diagnostic chains, quickly won regulatory approval to conduct Covid-19 tests, becoming one of the first private labs able to test the country's masses.
Volumes of longer-term rentals are surging as commuters seek the combination of safety and personal use, avoiding multiple users of the same scooters, says Anand Ayyadurai
Mexico, Ireland, Norway, are other countries to be elected; India and Mexico ran unopposed
At least 16 unicorns, including Ola and Byjus, have at least one Chinese investor; they have pumped in more than $5.8 billion in Indian startups over the past seven years
Even children are pressed into giving blood samples to build a sweeping genetic database that will add to Beijing's growing surveillance capabilities, raising questions about abuse and privacy
Dr. Inderjeet Singh explains how high blood pressure affects kidney. He also highlights high cholesterol as a risk factor for hypertension
Chinese companies have made deep inroads as investors, employers and suppliers; rolling that back in quick time is neither pragmatic nor feasible
How an amateur golfer, a pilot, a landscape architect and others are dealing with isolation, to protect their loved ones from a possible coronavirus spread
How companies like Delhivery, Clovia, Cars24 and JetSetGo have moved away from their core in the pandemic, or added to it
53 transfers in 28 years. That's how often IAS officer Ashok Khemka was transferred around; that's an average of 6.5 months versus the norm of two years. On this week's episode, the co-author of the book 'Just Transferred' chronicles the story of Khemka, an unlikely hero, whose tale also speaks of how democracy has been undermined by bureaucracy in India
Industries with slender margins must move quickly on reducing their cost structures to reflect decreased demand